Skip to content

Treatment of mixed anxiety and depression disorder by homoeopathy

An open label observational clinical study to find out the effectiveness of individualized homoeopathic medicines in the treatment of mixed anxiety and depression disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029177
Enrollment
50
Registered
2020-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F413- Other mixed anxiety disorders

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: Dose- Each dose shall consist of 4 cane sugar globules no.10, medicated with the indicated medicine, preserved in 90% v/v

Sponsors

The Calcutta Homoeopathic Medical College and Hospital Govt of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases suffering from MADD & diagnosed as per DSM-4. 2.Cases having HAM-A (18-30) and HAM-D (17-25). 3.Duration of symptom at least 1 month. 4.Literate patients who can read Bengali and/or English and/or Hindi. 5. Capability and willingness to give informed consent and to comply with the study procedures.

Exclusion criteria

Exclusion criteria: 1.Mild cases of MADD [HAM-A (less than 18) and HAM-D (less than 17) ] . 2.Severe or very severe cases of MADD [ HAM-A (more than 30) and HAM-D (more than 25)]; with or without suicide attempt. 3.Patients must not have been taking antidepressants or anxiolytic drugs at the time of inclusion. 4.Patients with any other psychiatric diseases other than MADD. 5.Homeopathic treatment for any chronic diseases eight weeks prior to enrollment in the drug. 6.Cases suffering from uncontrolled systemic illness or life-threatening infections. 7.Self-reported immune-compromised state. 8.Alcohol or other substance abuse. 9.Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Improvement of patients in regard to MADD will be access by Hamilton Anxiety Rating Scale (HAM-A) and Hamilton Depression Rating Scale (HAM-D)Timepoint: Baseline and after 3 months

Secondary

MeasureTime frame
The World Health Organization Quality of Life (WHOQOL-BREF)Timepoint: Baseline and after 3 months

Countries

India

Contacts

Public ContactHIMANGSU HAIT

The Calcutta Homoeopathic Medical College And Hospital

haitdrhimangsu@gmail.com9433565680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026